ergometrine

Also known as Ergotrate®, Methergine®, N-(2-Hydroxy-1-methylethyl)-D-(+)-lysergamide, D-lysergic acid 1-hydroxymethylethylamide, D-lysergic acid-L-propanolamide, [8beta(S)]-9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide,

Key facts

Drug.Watchedfields: changed
Drug.verifiedrevid: 443732517
Drug.image: Ergonovine-skeletal.svg
Drug.image_class: skin-invert-image
Drug.width: 200px
Drug.image2: Ergonovine 3D.png
Drug.image_class2: bg-transparent
Drug.width2: 200px
Drug.tradename: Ergotrate, Ergotrate Maleate
Drug.routes_of_administration: oral, intramuscular, intravenous
Drug.class: Serotonin receptor agonists; Uterotonic
Drug.ATC_prefix: G02

~6 min read

Article

16 sections

Contents

Medical uses
Side effects
Interactions
Pharmacology
Pharmacodynamics
Chemistry
Synthesis
Analogues
Natural occurrence
History
Society and culture
Recreational use
Legal status
See also
References
External links

Ergonovine, also known as ergometrine and lysergic acid propanolamide, is a medication used to cause contractions of the uterus to treat heavy vaginal bleeding after childbirth. It can be used either by mouth, by injection into a muscle, or injection into a vein.

Common side effects include high blood pressure, vomiting, seizures, headache, and low blood pressure. Other serious side effects include ergotism.